Phase 3 Mpox Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC
SafetyVaccinationChildren+3 more
Jean-Pierre Van geertruyden344 enrolled1 locationNCT06844487
Recruiting
Phase 3
Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease
MonkeypoxMpox
ANRS, Emerging Infectious Diseases480 enrolled12 locationsNCT05597735